Enzymatica wants to be a good stakeholder in the community and take responsibility for sustainable social development.
As a medical device company, Enzymatica focuses on human health and well-being, and wants to use resources, regardless of whether they are raw materials, energy or human, as wisely and sustainably as possible.
Regarding basic research, production and sales of products, the Company cooperates to a large extent with partners, many of whom actively work with sustainability issues.
Extensive market and strong presence on the home market
Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 5.6%, based on rolling 12-month data at year-end 2018/2019.
We are also building a strong distributor network – in 2018 we signed distributor agreements for South Africa, Hong Kong & Macau, and Japan.
Enzymatica AB
Ideon Science Park
SE-223 70 Lund, Sweden
Telefon: +46 46-286 31 00
E-mail: info@enzymatica.se
